Illustrative composite. Not a real person, not a testimonial.
An example week: what a well-prepared mushroom journey can look like
An illustrative composite, not a real person: preparation, a hard moment and how a sitter handled it, and what changed over the weeks after.
About this story
A. is an illustrative composite, written by us to show how the four-week plan can play out. A. is not a real person, nothing here is a testimonial, and nothing here predicts what will happen to you. Outcomes vary widely, and some people have lasting difficulties after a psilocybin experience. [Survey study of challenging experiences after ingesting psilocybin mushrooms: acute and enduring positive and negative consequences, Journal of Psychopharmacology, 2016, read 28 October 2026]
A. is a 38-year-old designer. Eighteen months after a parent's death, the work has stalled: ideas arrive, then die on the page. A. is not depressed by a doctor's measure, takes no medication, and has read that in trials participants were carefully screened and supported throughout. [Human hallucinogen research: guidelines for safety, Journal of Psychopharmacology, 2008, read 28 October 2026] A. considers a licensed session in Oregon, decides on a weekend at home with an old friend as sitter, and writes down the risks of that choice honestly.
3 weeks before
A. runs through the interaction checker (nothing applies), asks a sibling about family history (none of psychosis or bipolar disorder), and starts the intention journal. The first draft says “get my creativity back”. A week later it reads: “understand what stopped when Dad died.”
2 weeks before
A. asks J., a friend of twenty years who does not drink much and does not panic, to sit. They read the sitter guide together and sign the agreement: hand-holding if asked, nothing more; J. stays sober and stays until it is over; J. calls for help on any physical warning sign. A. clears the spare room and builds a three-hour, mostly wordless playlist.
The week before
A lighter dieta: no alcohol, one coffee a day, simple meals, no social media in the evenings. A. uses the dose calculator, chooses the low end of the moderate range, and weighs it on a kitchen scale.
The day
A light breakfast. They read the intention aloud. Effects begin within the hour: colour, then a heaviness in the chest.
The hard moment. Around the second hour, A. sits up and says “I want it to stop. I can't do this.” J. does not argue or reassure with promises. J. kneels at eye level, says “You took mushrooms. You're safe, I'm here, and this will pass,” and asks whether A. wants a hand to hold. A. takes it, lies back down, and J. suggests breathing out slowly. Peer support training calls this going through, not down: staying with someone in it rather than trying to make it stop. [Zendo Project guide: the four principles of psychedelic support, Zendo Project, read 28 October 2026] A. cries for a long time about the hospital room, then about the drawings A. used to make at the kitchen table as a child, with that parent watching.
By late afternoon A. is sitting up, eating an orange, quiet. J. stays until A. is clearly back, writes down the two sentences A. wants to remember, and goes home after dinner.
Days 1 to 3
A. sleeps nine hours and spends the next day walking. The day 1 journal entry is mostly a list of images. By day 3, one idea has settled: the stalled work had been a way of not finishing anything the parent would never see.
Weeks 1 to 4
A. joins an online integration circle and tells a therapist A. already sees. In week 3 A. tries one change: twenty minutes of drawing by hand each morning, unshown to anyone. Some mornings it works. A. reports, a month on, feeling less stuck and more able to start things, and also that the grief is closer to the surface than before. Neither is a cure, and both are worth talking through.
What A. would do differently
- Plan two clear days after, not one. The day after was tender.
- Tell the therapist before, not after.
- Agree with the sitter in advance on a few words to say in a hard moment, instead of improvising.
- Put the emergency plan on the fridge, not in a drawer.
What this composite does not show
Many experiences are harder than this one, and some people come away worse. In a survey of people describing their most difficult mushroom experience, 2.7% received medical help, and 7.6% of those whose experience was more than a year earlier sought treatment for lasting psychological symptoms. [Survey study of challenging experiences after ingesting psilocybin mushrooms: acute and enduring positive and negative consequences, Journal of Psychopharmacology, 2016, read 28 October 2026] Trial results come from screened volunteers with trained support, and people report very different things. Read the four-week plan and bad trip: what to do before relying on a story like this.
When a retreat or licensed centre is the better choice
A., in this composite, had no medication, no psychiatric history and a steady sitter. Many people do not, and for them a screened, staffed setting is the better choice.
If you take any medication on the interaction checker, have a personal or family history of psychosis or bipolar disorder, have a heart condition, or have nobody sober and steady to sit with you, a setting with screening and trained staff is the safer choice. In trials, participants were screened first and supported by trained monitors throughout. [Human hallucinogen research: guidelines for safety, Journal of Psychopharmacology, 2008, read 28 October 2026]
- All retreats and licensed centres, with prices and the law in each place
- Find your retreat: seven questions and a shortlist
- Licensed sessions in Oregon or Colorado, or retreats in the Netherlands and Jamaica
If you need help now
- 988 Suicide & Crisis Lifeline (US): call or text 988, any hour. 988lifeline.org
- Fireside Project (US): a psychedelic peer support line, call or text 62-FIRESIDE (623-473-7433). [Fireside Project: psychedelic peer support line, Fireside Project, read 28 October 2026]
- A medical emergency anywhere: call your local emergency number (911 in the US, 112 in the EU).